Top

European Journal of Medical Research

Published in:

01-12-2010 | Research

Whole blood coagulation and platelet activation in the athlete: A comparison of marathon, triathlon and long distance cycling

Authors: AA Hanke, A Staib, K Görlinger, M Perrey, D Dirkmann, P Kienbaum

Published in: European Journal of Medical Research | Issue 2/2010

Abstract

Introduction

Serious thrombembolic events occur in otherwise healthy marathon athletes during competition. We tested the hypothesis that during heavy endurance sports coagulation and platelets are activated depending on the type of endurance sport with respect to its running fraction.

Materials and Methods

68 healthy athletes participating in marathon (MAR, running 42 km, n = 24), triathlon (TRI, swimming 2.5 km + cycling 90 km + running 21 km, n = 22), and long distance cycling (CYC, 151 km, n = 22) were included in the study. Blood samples were taken before and immediately after completion of competition to perform rotational thrombelastometry. We assessed coagulation time (CT), maximum clot firmness (MCF) after intrinsically activation and fibrin polymerization (FIBTEM). Furthermore, platelet aggregation was tested after activation with ADP and thrombin activating peptide 6 (TRAP) by using multiple platelet function analyzer.

Results

Complete data sets were obtained in 58 athletes (MAR: n = 20, TRI: n = 19, CYC: n = 19). CT significantly decreased in all groups (MAR -9.9%, TRI -8.3%, CYC -7.4%) without differences between groups. In parallel, MCF (MAR +7.4%, TRI +6.1%, CYC +8.3%) and fibrin polymerization (MAR +14.7%, TRI +6.1%, CYC +8.3%) were significantly increased in all groups. However, platelets were only activated during MAR and TRI as indicated by increased AUC during TRAP-activation (MAR +15.8%) and increased AUC during ADP-activation in MAR (+50.3%) and TRI (+57.5%).

Discussion

While coagulation is activated during physical activity irrespective of type we observed significant platelet activation only during marathon and to a lesser extent during triathlon. We speculate that prolonged running may increase platelet activity, possibly, due to mechanical alteration. Thus, particularly prolonged running may increase the risk of thrombembolic incidents in running athletes.

Chan KL, Davies RA, Chambers RJ: Coronary thrombosis and subsequent lysis after a marathon. J Am Coll Cardiol 1984, 4: 1322–1325. 10.1016/S0735-1097(84)80157-6PubMedCrossRef

Disdier P, Harle , Swiader L, Gambarelli-Mouillac N, Weiller PJ: Retinal vein occlusions in a marathon runner. Presse Med 1992, 21: 582.PubMed

Gaudard A, Varlet-Marie E, Monnier JF, et al.: Exercise-induced central retinal vein thrombosis: possible involvement of hemorheological disturbances. A case report. Clin Hemorheol Microcirc 2002, 27: 115–122.PubMed

Scobie BA: Gastrointestinal emergencies with marathon-type running: omental infarction with pancreatitis and liver failure with portal vein thrombosis. N Z Med J 1998, 111: 211–212.PubMed

Thompson GR: Grand rounds--Hammersmith Hospital. Hazards of running a marathon. BMJ 1997, 314: 1023–1025. 10.1136/bmj.314.7086.1023PubMedCentralPubMedCrossRef

Whitson BA, Nath DS, Knudtson JR, Shumway SJ: Cardiopulmonary bypass in revascularization and fluid management of exercise-induced acute myocardial infarction. J Card Surg 2006, 21: 480–483. 10.1111/j.1540-8191.2006.00291.xPubMedCrossRef

Markov LN: The syndrome of disseminated intravascular coagulation in marathon athletes. Ter Arkh 1989, 61: 90–92.PubMed

Arai M, Yorifuji H, Ikematsu S, et al.: Influences of strenuous exercise (triathlon) on blood coagulation and fibrinolytic system. Thromb Res 1990, 57: 465–471. 10.1016/0049-3848(90)90262-BPubMedCrossRef

Dimitriadou C, Dessypris A, Louizou C, Mandalaki T: Marathon run II: Effects on platelet aggregation. Thromb Haemost 1977, 37: 451–455.PubMed

10.

Hilberg T, Glaser D, Reckhart C, Prasa D, Sturzebecher J, Gabriel HH: Blood coagulation and fibrinolysis after long-duration treadmill exercise controlled by individual anaerobic threshold. Eur J Appl Physiol 2003, 90: 639–642. 10.1007/s00421-003-0907-2PubMedCrossRef

11.

Hilberg T, Prasa D, Sturzebecher J, Glaser D, Schneider K, Gabriel HH: Blood coagulation and fibrinolysis after extreme short-term exercise. Thromb Res 2003, 109: 271–277. 10.1016/S0049-3848(03)00283-4PubMedCrossRef

12.

Mandalaki T, Dessypris A, Louizou C, Bossinakou I, Panayotopoulou C, Antonopoulou A: Marathon run I: effects on blood coagulation and fibrinolysis. Thromb Haemost 1977, 37: 444–450.PubMed

13.

Mandalaki T, Dessypris A, Louizou C, Panayotopoulou C, Dimitriadou C: Marathon Run III: effects on coagulation, fibrinolysis, platelet aggregation and serum cortisol levels. A 3-year study. Thromb Haemost 1980, 43: 49–52.PubMed

14.

Mockel M, Ulrich NV, Heller G Jr, et al.: Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 2001, 22: 337–343. 10.1055/s-2001-15649PubMedCrossRef

15.

Prisco D, Paniccia R, Bandinelli B, et al.: Evaluation of clotting and fibrinolytic activation after protracted physical exercise. Thromb Res 1998, 89: 73–78. 10.1016/S0049-3848(97)00293-4PubMedCrossRef

16.

Rock G, Tittley P, Pipe A: Coagulation factor changes following endurance exercise. Clin J Sport Med 1997, 7: 94–99. 10.1097/00042752-199704000-00004PubMedCrossRef

17.

Rocker L, Taenzer M, Drygas WK, Lill H, Heyduck B, Altenkirch HU: Effect of prolonged physical exercise on the fibrinolytic system. Eur J Appl Physiol Occup Physiol 1990, 60: 478–481. 10.1007/BF00705040PubMedCrossRef

18.

Siegel AJ, Stec JJ, Lipinska I, et al.: Effect of marathon running on inflammatory and hemostatic markers. Am J Cardiol 2001, 88: 918–920. 10.1016/S0002-9149(01)01909-9PubMedCrossRef

19.

Smith JE, Garbutt G, Lopes P, Pedoe DT: Effects of prolonged strenuous exercise (marathon running) on biochemical and haematological markers used in the investigation of patients in the emergency department. Br J Sports Med 2004, 38: 292–294. 10.1136/bjsm.2002.002873PubMedCentralPubMedCrossRef

20.

Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B: Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006, 4: 411–416. 10.1111/j.1538-7836.2006.01715.xPubMedCrossRef

21.

Sumann G, Fries D, Griesmacher A, et al.: Blood coagulation activation and fibrinolysis during a downhill marathon run. Blood Coagul Fibrinolysis 2007, 18: 435–440. 10.1097/MBC.0b013e328136c19bPubMedCrossRef

22.

Weiss C, Seitel G, Bartsch P: Coagulation and fibrinolysis after moderate and very heavy exercise in healthy male subjects. Med Sci Sports Exerc 1998, 30: 246–251.PubMedCrossRef

23.

Weiss C, Welsch B, Albert M, et al.: Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc 1998, 30: 1205–1210. 10.1097/00005768-199808000-00004PubMedCrossRef

24.

Hartert H: Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenschr 1948, 26: 577–583. 10.1007/BF01697545PubMedCrossRef

25.

Grogan R: Run, Pheidippides, Run! The story of the Battle of Marathon. Br J Sports Med 1981, 15: 186–189. 10.1136/bjsm.15.3.186PubMedCentralPubMedCrossRef

26.

Kinsey TE: Pheidippides and the Marathon run. Br J Sports Med 1981, 15: 285–286. 10.1136/bjsm.15.4.285PubMedCentralPubMedCrossRef

27.

Maron BJ, Poliac LC, Roberts WO: Risk for sudden cardiac death associated with marathon running. J Am Coll Cardiol 1996, 28: 428–431.PubMedCrossRef

28.

Van Camp SP, Bloor CM, Mueller FO, Cantu RC, Olson HG: Nontraumatic sports death in high school and college athletes. Med Sci Sports Exerc 1995, 27: 641–647.PubMedCrossRef

29.

Siscovick DS, Weiss NS, Fletcher RH, Lasky T: The incidence of primary cardiac arrest during vigorous exercise. N Engl J Med 1984, 311: 874–877. 10.1056/NEJM198410043111402PubMedCrossRef

30.

Tunstall Pedoe DS: Marathon cardiac deaths: the london experience. Sports Med 2007, 37: 448–450. 10.2165/00007256-200737040-00046PubMedCrossRef

31.

Willich SN, Lewis M, Lowel H, Arntz HR, Schubert F, Schroder R: Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 1993, 329: 1684–1690. 10.1056/NEJM199312023292302PubMedCrossRef

32.

van Loon BJ, Heere LP, Kluft C, Briet E, Dooijewaard G, Meinders AE: Fibrinolytic system during long-distance running in IDDM patients and in healthy subjects. Diabetes Care 1992, 15: 991–996. 10.2337/diacare.15.8.991PubMedCrossRef

33.

Holzheimer RG, Stautner-Bruckmann C: Calf pain in runners may be caused by venous insufficiency. Eur J Med Res 2008, 13: 218–220.PubMed

34.

Bartsch P, Welsch B, Albert M, Friedmann B, Levi M, Kruithof EK: Balanced activation of coagulation and fibrinolysis after a 2-h triathlon. Med Sci Sports Exerc 1995, 27: 1465–1470.PubMedCrossRef

35.

Li N, He S, Blomback M, Hjemdahl P: Platelet activity, coagulation, and fibrinolysis during exercise in healthy males: effects of thrombin inhibition by argatroban and enoxaparin. Arterioscler Thromb Vasc Biol 2007, 27: 407–413.PubMedCrossRef

36.

McCrath DJ, Cerboni E, Frumento RJ, Hirsh AL, nett-Guerrero E: Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005, 100: 1576–1583. 10.1213/01.ANE.0000155290.86795.12PubMedCrossRef

37.

Davi G, Patrono C: Platelet activation and atherothrombosis. N Engl J Med 2007, 357: 2482–2494. 10.1056/NEJMra071014PubMedCrossRef

38.

McNicol A, Israels SJ: Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 2008, 8: 99–117. 10.2174/187152908784533739PubMedCrossRef

39.

Cerneca E, Simeone R, Bruno G, Gombacci A: Coagulation parameters in senior athletes practicing endurance sporting activity. J Sports Med Phys Fitness 2005, 45: 576–579.PubMed

40.

Davidson RJ: March or exertional haemoglobinuria. Semin Hematol 1969, 6: 150–161.PubMed

41.

Robinson Y, Cristancho E, Boning D: Intravascular hemolysis and mean red blood cell age in athletes. Med Sci Sports Exerc 2006, 38: 480–483. 10.1249/01.mss.0000188448.40218.4cPubMedCrossRef

42.

Spicer AJ: Studies on march haemoglobinuria. Br Med J 1970, 1: 155–156. 10.1136/bmj.1.5689.155PubMedCentralPubMedCrossRef

43.

Ferrari E, Morgan G: Travel as a risk factor for venous thromboembolic disease. Eur J Med Res 2004, 9: 146–149.PubMed

Title: Whole blood coagulation and platelet activation in the athlete: A comparison of marathon, triathlon and long distance cycling
Authors: AA Hanke
A Staib
K Görlinger
M Perrey
D Dirkmann
P Kienbaum
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: European Journal of Medical Research / Issue 2/2010
Electronic ISSN: 2047-783X
DOI: https://doi.org/10.1186/2047-783X-15-2-59

At a glance: The STEP trials

Springer Medicine

Whole blood coagulation and platelet activation in the athlete: A comparison of marathon, triathlon and long distance cycling

Abstract

Introduction

Materials and Methods

Results

Discussion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Materials and Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 2/2010

Giant plexiform neurofibroma with hemorrhage in cranio-maxillofacial region as depicted on CT and MRI

Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity

Kaposi sarcoma in a HIV uninfected man who has sex with men

Cognitive impairment in patients with a schizoaffective disorder: a comparison with bipolar patients in euthymia

Posttraumatic severe infection of the ankle joint - long term results of the treatment with resection arthrodesis in 133 cases

Twenty-seven years follow-up of a patient with congenital retinocephalofacial vascular malformation syndrome and additional congenital malformations (Bonnet-Dechaume-Blanc syndrome or Wyburn-Mason syndrome)